丽珠医药前三季度净利超17亿元,特一药业净利狂飙985%,翰森制药1类新药来袭,恒瑞医药创新药新进展

谈医说药
Oct 23

博济医药:子公司广州华圣制药有限公司申报的“复方聚乙二醇电解质散(Ⅲ)”获得国家药品监督管理局核准签发的《药品注册证书》。该药品适用于内窥镜或放射检查、结肠手术前的成年人患者结肠清洁准备。百洋医药:公司与北京大学国际医院于2025年10月23日签署了《放射外科治疗中心合作协议》。根据协议,双方将共同建设并运营放射外科治疗中心,通过资源互补和优势协同的方式提高优质医疗资源的可及性。合作期限为八年,自...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10